Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
Gargiulo L, Ibba L, Malagoli P, Balato A, Bardazzi F, Burlando M, Carrera CG, Damiani G, Dapavo P, Dini V, Gaiani FM, Girolomoni G, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Mercuri SR, Travaglini M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: dapavo p. Front Immunol. 2024 Jan 11;14:1341708. doi: 10.3389/fimmu.2023.1341708. eCollection 2023. Front Immunol. 2024. PMID: 38274801 Free PMC article.
Risankizumab shows faster response in bio naïve than in bio-experienced psoriatic patients.
Mastorino L, Castelli F, Stroppiana E, Verrone A, Ortoncelli M, Susca S, Boskovic S, Passerini SG, Macagno N, Cariti C, Licciardello M, Solaroli C, Pertusi G, Aragone MG, Baggini G, Addese C, Leporati C, Peila R, Giura MT, Rossotto G, Pella P, Mocci L, Merlo G, Tiberio R, Graziola F, Quaglino P, Dapavo P, Ribero S. Mastorino L, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2022 Oct;36(10):e838-e841. doi: 10.1111/jdv.18314. Epub 2022 Jun 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35686942 No abstract available.
Optimization of systemic treatments for chronic plaque psoriasis. Recommendations for switching and transitioning.
Gisondi P, Amerio P, Amoroso GF, Antonucci VA, Bardazzi F, Buongiorno MR, Bruni P, Campanati A, Caproni M, Carlesimo M, Carrera CG, Cianchino G, Cimmino G, Costanzo A, Cozzani E, Dapavo P, D'amico D, De Simone C, Del Giglio M, Di Nuzzo S, Gai F, Galluccio AG, Goffredo A, Gualdi G, Guarneri C, Kokelj F, Lasagni C, Loconsole F, Longo V, Malagoli P, Miracapillo A, Mugheddu C, Parodi A, Pellegrino M, Peserico A, Piaserico S, Pistone G, Potenza C, Plumari A, Stingeni L, Strippoli D, Travaglino M, Girolomoni G. Gisondi P, et al. Among authors: dapavo p. G Ital Dermatol Venereol. 2013 Dec;148(6 Suppl 1):1-10. G Ital Dermatol Venereol. 2013. PMID: 24675369
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.
Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, Costanzo A, Conti A, Dapavo P, De Simone C, Foti C, Naldi L, Offidani A, Parodi A, Piaserico S, Prignano F, Rongioletti F, Stingeni L, Talamonti M, Girolomoni G. Gisondi P, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2017 May;31(5):774-790. doi: 10.1111/jdv.14114. Epub 2017 Feb 27. J Eur Acad Dermatol Venereol. 2017. PMID: 28244153
Elderly psoriatic patients under biological therapies: an Italian experience.
Ricceri F, Bardazzi F, Chiricozzi A, Dapavo P, Ferrara F, Mugheddu C, Romanelli M, Rongioletti F, Prignano F. Ricceri F, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2019 Jan;33(1):143-146. doi: 10.1111/jdv.15139. Epub 2018 Jul 6. J Eur Acad Dermatol Venereol. 2019. PMID: 29906311
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.
Marzano AV, Genovese G, Casazza G, Fierro MT, Dapavo P, Crimi N, Ferrucci S, Pepe P, Liberati S, Pigatto PD, Offidani A, Martina E, Girolomoni G, Rovaris M, Foti C, Stingeni L, Cristaudo A, Canonica GW, Nettis E, Asero R. Marzano AV, et al. Among authors: dapavo p. J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924. doi: 10.1111/jdv.15350. Epub 2018 Dec 7. J Eur Acad Dermatol Venereol. 2019. PMID: 30451325 Free article.
Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.
Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò SP, Chiricozzi A, Dapavo P, De Simone C, Fargnoli MC, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani AM, Piaserico S, Prignano F, Stingeni L, Pellacani G. Conti A, et al. Among authors: dapavo p. Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21. Br J Dermatol. 2019. PMID: 30578668 No abstract available.
152 results